MiMedx Group, Inc short interest in 2024
In 2024, MiMedx Group, Inc's disclosed short interest ran from 3.70% of shares outstanding on 12 Jan 2024 to 3.05% on 31 Dec 2024, a change of -0.65 percentage points. The year's high was 4.20% on 15 Feb 2024 and its low 2.33% on 29 Nov 2024, averaging 3.34% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.86 days on 15 Jul 2024. Full history: MiMedx Group, Inc.
Cite this page
By year: 2018 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 3.70% (12 Jan 2024)
- End of year
- 3.05% (31 Dec 2024)
- Change
- -0.65 pp
- High
- 4.20% (15 Feb 2024)
- Low
- 2.33% (29 Nov 2024)
- Average
- 3.34%
- Highest days to cover
- 10.86 (15 Jul 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 3.70% | 6.04 | |
| 31 Jan 2024 | 3.83% | 8.91 | |
| 15 Feb 2024 | 4.20% | 7.16 | |
| 29 Feb 2024 | 3.60% | 6.56 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 3.76% | 5.61 | |
| 28 Mar 2024 | 3.52% | 5.85 | |
| 15 Apr 2024 | 3.75% | 6.95 | |
| 30 Apr 2024 | 3.83% | 7.20 | 10-Q filed, results (8-K) |
| 15 May 2024 | 3.98% | 6.59 | |
| 31 May 2024 | 3.78% | 8.76 | |
| 14 Jun 2024 | 3.80% | 9.72 | |
| 28 Jun 2024 | 3.34% | 4.42 | |
| 15 Jul 2024 | 3.42% | 10.86 | |
| 31 Jul 2024 | 3.30% | 8.07 | 10-Q filed, results (8-K) |
| 15 Aug 2024 | 3.29% | 5.37 | |
| 30 Aug 2024 | 3.17% | 6.88 | |
| 13 Sep 2024 | 3.18% | 7.49 | |
| 30 Sep 2024 | 2.78% | 7.10 | |
| 15 Oct 2024 | 2.74% | 10.27 | |
| 31 Oct 2024 | 2.72% | 8.21 | 10-Q filed, results (8-K) |
| 15 Nov 2024 | 2.40% | 2.58 | |
| 29 Nov 2024 | 2.33% | 3.96 | |
| 13 Dec 2024 | 2.62% | 4.80 | |
| 31 Dec 2024 | 3.05% | 6.46 |
See also: MiMedx Group, Inc's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.